ADIPOQ and Glucose intolerance: Increased angiotensin II levels and AT1 receptor activity have been shown to decrease adiponectin production, promote oxidative stress, and impair insulin signalling, thereby exacerbating insulin resistance and glucose intolerance [27,28].